Repinotan, a Selective 5-HT1A-R-Agonist, Antagonizes Morphine-Induced Ventilatory Depression in Anesthetized Rats

@article{Guenther2010RepinotanAS,
  title={Repinotan, a Selective 5-HT1A-R-Agonist, Antagonizes Morphine-Induced Ventilatory Depression in Anesthetized Rats},
  author={Ulf Guenther and Hermann Wrigge and Nils Ulrich Theuerkauf and Michael Boettcher and Georg Wensing and Joerg Zinserling and Christian Putensen and Andreas Hoeft},
  journal={Anesthesia \& Analgesia},
  year={2010},
  volume={111},
  pages={901–907}
}
BACKGROUND:Spontaneous breathing during mechanical ventilation improves arterial oxygenation and cardiovascular function, but is depressed by opioids during critical care. Opioid-induced ventilatory depression was shown to be counteracted in anesthetized rats by serotonin(1A)-receptor (5-HT1A-R)-agonist 8-OH-DPAT, which cannot be applied to humans. Repinotan hydrochloride is a selective 5-HT1A-R-agonist already investigated in humans, but the effects on ventilation and nociception are unknown… 

Figures and Tables from this paper

Selective 5-HT1A-R-agonist Repinotan Prevents Remifentanil-induced Ventilatory Depression and Prolongs Antinociception

Repinotan prevented remifentanil-induced ventilatory depression in spontaneously breathing, anesthetized rats and prolonged the profound antinociception after discontinuation of remifENTanil infusion.

5-HT1A Receptor Agonist Befiradol Reduces Fentanyl-induced Respiratory Depression, Analgesia, and Sedation in Rats

The reversal of opioid-induced respiratory depression and sedation by befiradol in adult rats was robust, whereas involved mechanisms are unclear, however, there were adverse concomitant decreases in fentanyl-induced analgesia and altered baseline ventilation, nociception, and behavior.

Central administration of CXCR4 antagonist prevents the development of peripheral neuropathic pain and modulates the spinal expression of neuropeptides and pro-inflammatory cytokines in mice: 9AP1-9

Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats, while analgesia was not impaired and the expected ef fect could have been uncovered using a study design wih preliminary established opioid-induced respiratory depression and an additional loss of awareness.

Dual mechanisms of opioid-induced respiratory depression in the inspiratory rhythm-generating network

It is concluded that hyperpolarization of MOR-expressing preBötC neurons alone does not phenocopy OIRD, and the effects of MOR activation are twofold: 1) pre-inspiratory spiking is reduced and 2) excitatory synaptic transmission is suppressed, thereby disrupting network-driven rhythmogenesis.

Non-analgesic effects of opioids: opioid-induced respiratory depression.

A novel approach is aimed at the reduction of respiratory depression from opioid-activation of (micro-)glia cells in the pons and brainstem using micro-glia cell stabilizers which seems an attractive alternative to the classical reversal strategies with naloxone.

Averting Opioid-induced Respiratory Depression without Affecting Analgesia.

None of the experimental drugs are adequate for therapeutic use in opioid-induced respiratory depression and all need further study of efficacy and toxicity, but all do highlight potential mechanisms of action and possible templates for further study and development.

Sources of Inspiration: A Neurophysiologic Framework for Understanding Anesthetic Effects on Ventilatory Control

Until reliable means for reversing drug-induced Ventilatory depression are developed, prompt recognition of ventilatory insufficiency and initiation of resuscitative measures remain the keys to patient safety.

References

SHOWING 1-10 OF 48 REFERENCES

The Counteraction of Opioid-Induced Ventilatory Depression by the Serotonin 1A-Agonist 8-OH-DPAT Does Not Antagonize Antinociception in Rats In Situ and In Vivo

5-HT1A-R-agonist 8-OH-DPAT activates spontaneous breathing without diminishing opioid-induced antinociception in rats.

Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors.

Results indicate that activation of central nervous system 5-HT(1A) receptors is an effective way of reversing morphine-induced respiratory depression, and is the third model of disturbed respiratory function in which drugs that stimulate 5- HT(1a) receptors have been shown to restore breathing to near-normal levels.

The potency of different serotonergic agonists in counteracting opioid evoked cardiorespiratory disturbances

5-HT1AR agonists may provide a useful tool to counteract opioid-mediated cardiorespiratory disturbances during treatment of severe pain, and are supported by the finding that 5- HT1AR was more densely expressed in key brainstem nuclei for cardiOREspiratory control compared with 5-HT4(a)R.

The Partial 5‐Hydroxytryptamine1A Receptor Agonist Buspirone does not Antagonize Morphine‐induced Respiratory Depression in Humans

Oral co‐administration of a high dose of the clinically available 5‐HT1A agonist buspirone cannot be advised as a remedy for opioid‐induced respiratory depression, indicated by its lack of anti‐respiratory depressive effects and by the buspir one‐associated increase of morphine‐induced nausea.

Profound, Non-Opioid Analgesia Produced by the High-Efficacy 5-HT1A Agonist F 13640 in the Formalin Model of Tonic Nociceptive Pain

The results help to establish large-magnitude 5-HT1A receptor activation as a new molecular mechanism of profound, central analgesia and suggest that F 13640 may be particularly effective against pain arising from severe tonic nociceptive stimulation.

Antinociceptive role of 5-HT1A receptors in rat spinal cord.

5-HT1A receptors in the spinal cord are involved in the nociceptive mechanisms assessed by noxious electrical stimuli, and other 5- HT1 receptors (non 5-HT 1A receptors) are involvement in the spinally mediated antinociception assessed by thermal noxious stimuli.